Literature DB >> 1490501

Significance of white matter lucencies in posthypoxic-ischemic encephalopathy: comparison of clinical status and of computed and positron emission tomographic findings.

J De Reuck1, D Decoo, J Vienne, K Strijckmans, I Lemahieu.   

Abstract

The clinical status and the computed and positron tomographic findings were compared in 10 patients with sequelae of hypoxic-ischemic encephalopathy after cardiopulmonary arrest and successful resuscitation. Conscious patients with moderate neuropsychiatric deficits had no significant computed tomography (CT) scan changes and normal values of regional cerebral blood flow and oxygen consumption, while patients in vegetative state had definite cerebral atrophy on CT scan and a severe and widespread decrease of regional cerebral blood flow and oxygen consumption. This decrease was even more pronounced in vegetative patients with the worst neurological score and with CT scans demonstrating additional diffuse white matter lucencies and hypodensities in the basal ganglia. In this group of patients increased regional oxygen extraction rates mainly in the white matter indicated the occurrence of delayed ischemic changes. The positron emission tomography and CT findings correlated well with the degree of posthypoxic-ischemic damage and the clinical status of the studied subjects.

Entities:  

Mesh:

Year:  1992        PMID: 1490501     DOI: 10.1159/000116856

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  2 in total

Review 1.  Early prediction of individual outcome following cardiopulmonary resuscitation: systematic review.

Authors:  P Kaye
Journal:  Emerg Med J       Date:  2005-10       Impact factor: 2.740

2.  Brain water intoxication and CT hypolucencies in ovarian hyperstimulation syndrome complicating gametes intrafallopian transfer (GIFT) and tubal pregnancy.

Authors:  M Onofrj; A Thomas; D Melchionda; T Fulgente; A Costantini; M Scesi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-02       Impact factor: 10.154

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.